Funding Opportunities

Innovate UK, SBRI Healthcare & NHS

 

SBRI

The Small Business Research Initiative for Healthcare (SBRI Healthcare) is an NHS England initiative, championed by the Academic Health Science Networks (AHSNs), which supports a programme of competitions inviting companies to come forward with their ideas and new technologies for known NHS challenges. These ideas are assessed and a fully funded development contract is agreed between the company and the NHS.

The SBRI Healthcare programme has two primary-phases that start with an initial identification of unmet need, undertaken by clinicians. Challenges are offered to industry to test the feasibility of their ideas and these projects, if successful, can result in a contract to develop the product

SBRI Healthcare is a fast track, simplified process that enables the NHS to work with industry to tackle known challenges. Targeted at SMEs and early stage businesses it gives vital funding for a critical stage of product development. For details about how to apply and current and future completion thematic areas visit www.sbrihealthcare.co.uk 

GOVERNMENT

Dept of Health: Strategic stockpile of medicines
This procurement exercise is intended to establish a framework agreement against which Public Health England would call-off their requirements for the stockpile of emergency medicines.
Deadline: 30 June 2020
Click here for more information

INNOVATE UK

Innovate UK: ISCF Healthy Ageing Trailblazers: Stage 1
This is stage 1 of a 2-stage competition. A total fund of up to £1.5 million is on offer for stage 1 to conduct research and develop a business plan for a healthy ageing ‘trailblazer’.
The aim of the Trailblazers is to encourage businesses and public sector led collaborations, including social enterprises, to develop and demonstrate how products, services and business models which support people as they age will be adopted at scale.
This is stage 1 of a 2-stage competition. You can apply for a grant of up to £100,000 to conduct research and develop a business plan. For stage 1 of the competition you can apply as a single applicant. Stage 2 proposals must be collaborative.
Deadline: 27 November 2019
Click here for more information

Innovate UK: Business Loans
The aim of the competition for innovation loans is to help businesses to overcome the barriers to their cutting-edge ideas becoming sustainable commercial products. Businesses need to show they could not get suitable finance from other sources.
Applicants must demonstrate:
• a clear game-changing and/or disruptive idea
• a strong and deliverable business plan
• the necessary skills and experience to run and complete the project successfully and on time
• awareness of all the main risks the project will face
• sound, practical financial plans and timelines that represent good value for money
• a clear plan to deliver growth through commercialisation
Deadline: 27 November 2019
Click here for more information.

Knowledge Transfer Partnerships: Next Funding Round
Projects can focus on any technology or industry area, and last between 1 to 3 years.
Applicants must:
• focus on a specific project
• set out the nature and goals of the project
• give details of who will take part
• establish what the graduate is expected to deliver
Deadline: 11 December 2019
Click here for more information.

Innovate UK: Innovative Medical Technologies Evaluation
The Office for Life Sciences will work with Innovate UK to invest up to £1.5 million in innovation projects. These will support developers of innovative medical devices, diagnostics and regulated digital technology to evaluate their product in a real-world clinical setting.
All projects must be led by a UK based SME. You can choose from 2 options:
1. Planning and preparation for a study, for which total eligible project costs can be up to £100,000.
2. A study to collect clinical performance and cost-effectiveness data, for which total project costs can be up to £500,000.
This competition provides support for SMEs to develop an evidence base for products that address NHS priorities. Our support will allow companies to collect and analyse clinical performance and cost effectiveness data in an NHS setting.
Priority will be given to projects that are related to:
• ageing well
• cancer
• digital transformation
• learning disabilities and autism
• mental health
• personalised care
• prevention
• primary care
• starting well
• stroke
• workforce
Deadline: 11 December 2019
Click here for more information.

Innovate UK: Smart Loans
The competition will support a range of projects from short feasibility studies to larger research and development projects and experimental development lasting up to 3 years.
Applicants must show they have:
• a game-changing idea that could lead to commercially viable new products, processes or services
• a strong business plan and a plan to deliver significant economic impact
Deadline: 8 January 2020.
Click here to find out more.

Innovate UK: Revolutionising cancer treatment with genomics
The competition aims to encourage new targeted cancer treatments based on the molecular signatures of cancer.
Projects must use whole genome sequencing to analyse cancer and can adopt various approaches including development of reporting tools, identification of molecular signatures, identification of therapeutic targets, and new genetic signatures.
They can focus on one or more of:
• improving diagnosis and prognosis of cancer and selection of therapies
• analysis of complex molecular signatures
• identification of tumours of unknown primary origin
• further analysis of existing whole genome sequence data held by Genomics England
• the system of sample collection provided by the genomic medicine centres
The competition will support a range of work from short feasibility studies to partners working on larger research and development projects.
o businesses of any size may apply, and all projects must include at least 1 SME
o we expect projects to range in size between £50,000 and £1 million
Deadline: 22 January 2020
Click here to find out more.

NHS TENDERS

NHS England: Supply of various medical products
Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema

Specialised – Bleeding Disorders

Specialised – Normal Human Immunoglobulins 

Open future opportunity – This means that the buyer is not yet ready to invite applications, but early notification has been provided and some dialogue may be possible.

NHS Supply Chain: Non-Invasive Ventilation, Sleep Therapy and Sleep Monitoring
Non-Invasive Ventilation consisting of CPAP, Bi-level and High Flow Therapy devices with associated consumables, sleep therapy devices consisting of CPAP and APAP with associated consumables, sleep monitoring devices consisting of polysomnography, polygraph, respiratory inductive plethysmography, pulse oximetry, blood oxygen saturation sensors and sleep and respiratory managed services consisting of clinical training, patient therapy data monitoring services, consumable management and patient assistance.
Deadline: 1 December 2019
Click here for more information.

NHS Supply Chain: Urology Bowel and Faecal Management
The Framework Agreement will look to include the following range of products – Baby Urine Collection, Bowel and Faecal Management Kits, Catheters, Kits and Maintenance, Catheter accessories, Straps, Valves etc, Catheter Gels, Enuresis Alarms, Mid-Stream Urine Collection, Nephrostomy Urine Drainage, Personal hygiene cleansers, Creams and Foams, Polypropylene Urinals and Funnels, Sheaths, Spigots, Superpubic Catheters, Urine Drainage, Urine Drainage Bags, Urine Meters, Urodynamics. It is anticipated that initial expenditure will be in the region of £18,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term is £78,000,000
Deadline: 11 December 2019
Click here for more information.

NHS Supply Chain: External Breasts Prostheses and Associated Products
The Framework Agreement will look to include the following range of products – Silicone Full Prosthesis, Silicone Partial Prosthesis, Soft Form Temporary Prosthesis and Post-Operative Bras and Accessories. It is anticipated that initial expenditure will be in the region of £5,000,000 to £8,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term is £20,000,000 to £32,000,000.
Deadline: 24 January 2020
Click here for more information.

NHS Supply Chain: Robotic Surgical Equipment
To provide a framework for robotic surgical equipment and associated accessories. NHS Supply Chain is conducting market research into robotic surgical equipment, including related accessories/consumables, that cover a wide range of medical procedures including, but not limited to: general surgery, laparoscopic and rthopaedic. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 10 000 000 GBP in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value over the total Framework Agreement term (including any extension options and growth) is 50 000 000 GBP.
Deadline: 3 February 2020
Click here for more information.

NHS Supply Chain: Sexual Health and Associated Products
The purpose of this notice is to draw attention to a procurement that NHS Supply Chain intends to commence during the subsequent 12 months. The invitation to tender will be the subject of a separate notice and it is that notice to which potential suppliers will need to respond at the appropriate time.
Deadline: 13 March 2020
Click here for more information.

NHS Calderdale CCG: Care Closer to Home
NHS Calderdale CCG is acting in its capacity as commissioner for healthcare services on behalf of the registered population of Calderdale.
This notice is to advise that the commissioner has determined to seek to develop an alliance in respect of the currently contracted providers of services identified within the scope of ‘Care Closer to Home’. Over the next two years, this will entail the providers of services developing and entering into an overarching agreement with the commissioner and other providers to deliver services under existing service contracts in a more collaborative and integrated way to the population served by the CCG.
During the term of the developmental stage outlined above Commissioners will work to develop a strategy for the future commissioning of services and where appropriate, procurement.
Deadline: 31 March 2021
Click here for more information.

NHS National Framework Agreement for the Home Delivery Service – Home Parenteral Nutrition
Deadline: ongoing
Click here for more information